Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel ketoreductase mutant enables high-purity pharmaceutical intermediates manufacturing with substantial cost reduction and enhanced supply chain reliability for global partners.
Patent CN105384799A details a hybrid solid-liquid phase synthesis for sinapultide. This method offers high purity and cost reduction in peptide manufacturing.
Discover advanced synthesis for imidazo[1,2-a]pyridine intermediates via Lewis acid catalysis. Enhance supply chain reliability and reduce manufacturing costs with scalable protocols.
Novel synthesis route for Dogliptin intermediate CN118812408A. High yield, scalable process for reliable pharmaceutical intermediate supplier.
Patent CN111620793A reveals a mild copper-catalyzed route for high-purity chiral nitriles. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable supply solutions.
Patent CN109402074B reveals high-activity monooxygenase mutants for chiral sulfoxide production. Discover cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain solutions.
Patent CN1912192B reveals a green electrochemical route for 7-keto lithocholic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Advanced phase transfer catalysis method for high-purity 9-(2-hydroxyethyl)carbazole. Reduces side reactions and ensures reliable pharmaceutical intermediate supply chains.
Patent CN103087132A reveals oxidizing agent method for beta-nucleosides. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN107674026B details a high-yield CBS reduction route for ruxolitinib intermediates. This method ensures superior stereoselectivity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN103102357A details a novel ethanol-water crystallization method for Cefuroxime sodium, offering safer production, superior purity, and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN1082949C details a copper-catalyzed route for CRF antagonist intermediates. Discover cost-effective manufacturing and supply chain advantages for high-purity heterocycles.
Patent CN102060719A reveals a safer catalytic hydrogenation route for Midodrine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115850238B enables high-purity Vonoprazan intermediate production with enhanced supply chain stability and cost efficiency for global buyers.
Patent CN112608359B reveals a continuous tubular process for steroid intermediates, offering superior yield and cost reduction in pharmaceutical manufacturing.
Novel three-step route for 5-methoxy-2-phenoxyaniline enhances safety and supply chain stability for global pharmaceutical intermediates manufacturing partners.
Novel solid intermediate process for Azelastine HCl improves stability and purity above 99 percent. This cost-effective manufacturing solution ensures supply chain reliability for global pharmaceutical partners.
Patent CN104803959B reveals a safer methylcyclohexane solvent system for simvastatin synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel asymmetric reduction route ensures high ee value and yield for Tegoprazan intermediate, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturing partners.
Patent CN114409608A details a novel route for ergothioneine production. High yield, scalable process for antioxidant manufacturing and reliable supply chain solutions.